Home › Compare › AGYTF vs O

AGYTF vs O: Dividend Comparison 2026

AGYTF yields 1818.18% · O yields 5.28%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 AGYTF wins by $4103414683.80M in total portfolio value
10 years
AGYTF
AGYTF
● Live price
1818.18%
Share price
$0.11
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4103414683.84M
Annual income
$3,702,796,788,756,407.00
Full AGYTF calculator →
O
Realty Income Corporation
● Live price
5.28%
Share price
$61.18
Annual div
$3.23
5Y div CAGR
15.1%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$34.2K
Annual income
$5,098.20
Full O calculator →

Portfolio growth — AGYTF vs O

📍 AGYTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodAGYTFO
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, AGYTF + O cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
AGYTF pays
O pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

AGYTF
Annual income on $10K today (after 15% tax)
$154,545.45/yr
After 10yr DRIP, annual income (after tax)
$3,147,377,270,442,946.00/yr
O
Annual income on $10K today (after 15% tax)
$448.90/yr
After 10yr DRIP, annual income (after tax)
$4,333.47/yr
At 15% tax rate, AGYTF beats the other by $3,147,377,270,438,612.50/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of AGYTF + O for your $10,000?

AGYTF: 50%O: 50%
100% O50/50100% AGYTF
Portfolio after 10yr
$2051707341.94M
Annual income
$1,851,398,394,380,752.50/yr
Blended yield
90.24%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on O right now

AGYTF
No analyst data
Altman Z
-5.5
Piotroski
2/9
O
Analyst Ratings
13
Buy
18
Hold
3
Sell
Consensus: Hold
Price Target
$64.00
+4.6% upside vs current
Range: $60.00 — $69.00
Altman Z
1.0
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

AGYTF buys
0
O buys
0
No recent congressional trades found for AGYTF or O in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricAGYTFO
Forward yield1818.18% ✓5.28%
Annual dividend / share$2.00$3.23 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.1% ✓
Portfolio after 10y$4103414683.84M ✓$34.2K
Annual income after 10y$3,702,796,788,756,407.00 ✓$5,098.20
Total dividends collected$4074760433.31M ✓$20.7K
Payment frequencyquarterlymonthly
SectorStockREIT

Year-by-year: AGYTF vs O ($10,000, DRIP)

YearAGYTF PortfolioAGYTF Income/yrO PortfolioO Income/yrGap
1← crossover$192,518$181,818.18$10,818$607.86+$181.7K → AGYTF
2$3,477,331$3,271,336.99$11,786$741.30+$3.47M → AGYTF
3$58,943,217$55,222,471.89$12,944$910.50+$58.93M → AGYTF
4$937,891,469$874,822,227.57$14,343$1,127.28+$937.88M → AGYTF
5$14,012,869,532$13,009,325,660.38$16,053$1,408.17+$14012.85M → AGYTF
6$196,647,994,247$181,654,223,846.76$18,167$1,776.65+$196647.98M → AGYTF
7$2,592,865,386,485$2,382,452,032,641.56$20,815$2,266.60+$2592865.37M → AGYTF
8$32,132,661,421,271$29,358,295,457,731.54$24,179$2,927.66+$32132661.40M → AGYTF
9$374,409,247,740,494$340,027,300,019,734.44$28,521$3,833.95+$374409247.71M → AGYTF
10$4,103,414,683,838,736$3,702,796,788,756,407.00$34,218$5,098.20+$4103414683.80M → AGYTF

AGYTF vs O: Complete Analysis 2026

AGYTF — Stock

Allergy Therapeutics plc, a biotechnology company, engages in the research and development of allergy treatments. The company sells injectable and sublingual allergen-specific immunotherapies; and offers prescription for the treatment of pollen-related allergies particularly to grasses, weeds, and trees, as well as diagnostics. Its products include Pollinex Quattro, Oralvac, Venomil, ImmunoBON, Synbiotics, Acarovac Plus, Penicillin diagnostics, Pollinex, and VLP Peanut. The company also develops allergy vaccines for trees, grass, house dust mite, and pets with fur/hair, as well as peanut allergy vaccines. It operates in Central Europe, Southern Europe, the United Kingdom, and internationally. Allergy Therapeutics plc was incorporated in 2004 and is headquartered in Worthing, the United Kingdom.

Full AGYTF Calculator →

O — REIT

Realty Income, The Monthly Dividend Company, is an S&P 500 company dedicated to providing stockholders with dependable monthly income. The company is structured as a REIT, and its monthly dividends are supported by the cash flow from over 6,500 real estate properties owned under long-term lease agreements with our commercial clients. To date, the company has declared 608 consecutive common stock monthly dividends throughout its 52-year operating history and increased the dividend 109 times since Realty Income's public listing in 1994 (NYSE: O). The company is a member of the S&P 500 Dividend Aristocrats index. Additional information about the company can be obtained from the corporate website at www.realtyincome.com.

Full O Calculator →
📬

Get this AGYTF vs O comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

AGYTF vs SCHDAGYTF vs JEPIAGYTF vs KOAGYTF vs MAINAGYTF vs STAGAGYTF vs ADCAGYTF vs NNNAGYTF vs VICI

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.